A systematic review of biomarkers for disease progression in Alzheimer's disease.

<h4>Background</h4>Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David J M McGhee, Craig W Ritchie, Paul A Thompson, David E Wright, John P Zajicek, Carl E Counsell
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ff5c14770f064f16b884a63baec52225
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!